Loading...
BIOSK logo

Unibios Holdings S.A.ATSE:BIOSK Stock Report

Market Cap €45.8m
Share Price
€2.72
€4.2
35.2% undervalued intrinsic discount
1Y89.5%
7D1.9%
Portfolio Value
View

Unibios Holdings S.A.

ATSE:BIOSK Stock Report

Market Cap: €45.8m

Unibios Holdings (BIOSK) Stock Overview

Through its subsidiaries, develops and installs water treatment and recycling systems in Europe, Africa, and the Middle East. More details

BIOSK fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health4/6
Dividends0/6

BIOSK Community Fair Values

Create Narrative

See what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.

Unibios Holdings S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Unibios Holdings
Historical stock prices
Current Share Price€2.72
52 Week High€3.30
52 Week Low€1.40
Beta0.37
1 Month Change-2.86%
3 Month Change-4.56%
1 Year Change89.55%
3 Year Change345.90%
5 Year Change828.33%
Change since IPO-94.57%

Recent News & Updates

Unibios Holdings (ATH:BIOSK) Strong Profits May Be Masking Some Underlying Issues

Oct 08
Unibios Holdings (ATH:BIOSK) Strong Profits May Be Masking Some Underlying Issues

Recent updates

Unibios Holdings (ATH:BIOSK) Strong Profits May Be Masking Some Underlying Issues

Oct 08
Unibios Holdings (ATH:BIOSK) Strong Profits May Be Masking Some Underlying Issues

Unibios Holdings (BIOSK.AT) – Growth Potential from Greek Water Projects and International Expansion

This is clearly written as an analysis/opinion , so you won’t have compliance issues posting it as-is. Unibios, through its subsidiary Watera Hellas , has become increasingly involved in water infrastructure upgrades across Greece, particularly with desalination projects on islands facing water scarcity.

There's Reason For Concern Over Unibios Holdings S.A.'s (ATH:BIOSK) Massive 51% Price Jump

Jul 24
There's Reason For Concern Over Unibios Holdings S.A.'s (ATH:BIOSK) Massive 51% Price Jump

Earnings Not Telling The Story For Unibios Holdings S.A. (ATH:BIOSK) After Shares Rise 41%

May 30
Earnings Not Telling The Story For Unibios Holdings S.A. (ATH:BIOSK) After Shares Rise 41%

Is Unibios Holdings (ATH:BIOSK) A Risky Investment?

May 27
Is Unibios Holdings (ATH:BIOSK) A Risky Investment?

Unibios Holdings (ATH:BIOSK) Might Have The Makings Of A Multi-Bagger

Apr 08
Unibios Holdings (ATH:BIOSK) Might Have The Makings Of A Multi-Bagger

The Return Trends At Unibios Holdings (ATH:BIOSK) Look Promising

Dec 20
The Return Trends At Unibios Holdings (ATH:BIOSK) Look Promising

Is Unibios Holdings (ATH:BIOSK) Using Too Much Debt?

Nov 21
Is Unibios Holdings (ATH:BIOSK) Using Too Much Debt?

Unibios Holdings (ATH:BIOSK) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Oct 07
Unibios Holdings (ATH:BIOSK) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

What Unibios Holdings S.A.'s (ATH:BIOSK) 32% Share Price Gain Is Not Telling You

Aug 08
What Unibios Holdings S.A.'s (ATH:BIOSK) 32% Share Price Gain Is Not Telling You

Investor Optimism Abounds Unibios Holdings S.A. (ATH:BIOSK) But Growth Is Lacking

Jan 05
Investor Optimism Abounds Unibios Holdings S.A. (ATH:BIOSK) But Growth Is Lacking

Unibios Holdings (ATH:BIOSK) Takes On Some Risk With Its Use Of Debt

Oct 05
Unibios Holdings (ATH:BIOSK) Takes On Some Risk With Its Use Of Debt

Investors Will Want Unibios Holdings' (ATH:BIOSK) Growth In ROCE To Persist

Jul 26
Investors Will Want Unibios Holdings' (ATH:BIOSK) Growth In ROCE To Persist

Returns Are Gaining Momentum At Unibios Holdings (ATH:BIOSK)

Nov 17
Returns Are Gaining Momentum At Unibios Holdings (ATH:BIOSK)

Returns At Unibios Holdings (ATH:BIOSK) Are On The Way Up

May 20
Returns At Unibios Holdings (ATH:BIOSK) Are On The Way Up

Unibios Holdings (ATH:BIOSK) May Have Issues Allocating Its Capital

Jan 04
Unibios Holdings (ATH:BIOSK) May Have Issues Allocating Its Capital

Unibios Holdings (ATH:BIOSK) Has Some Difficulty Using Its Capital Effectively

Aug 21
Unibios Holdings (ATH:BIOSK) Has Some Difficulty Using Its Capital Effectively

Unibios Holdings (ATH:BIOSK) Use Of Debt Could Be Considered Risky

May 05
Unibios Holdings (ATH:BIOSK) Use Of Debt Could Be Considered Risky

Returns On Capital At Unibios Holdings (ATH:BIOSK) Paint An Interesting Picture

Mar 01
Returns On Capital At Unibios Holdings (ATH:BIOSK) Paint An Interesting Picture

Shareholder Returns

BIOSKGR MachineryGR Market
7D1.9%-0.3%0.8%
1Y89.5%52.8%45.5%

Return vs Industry: BIOSK exceeded the Greek Machinery industry which returned 52.8% over the past year.

Return vs Market: BIOSK exceeded the Greek Market which returned 45.5% over the past year.

Price Volatility

Is BIOSK's price volatile compared to industry and market?
BIOSK volatility
BIOSK Average Weekly Movement7.5%
Machinery Industry Average Movement7.1%
Market Average Movement4.9%
10% most volatile stocks in GR Market7.5%
10% least volatile stocks in GR Market3.0%

Stable Share Price: BIOSK's share price has been volatile over the past 3 months compared to the Greek market.

Volatility Over Time: BIOSK's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Greek stocks.

About the Company

FoundedEmployeesCEOWebsite
194083Nik Mavrikioswww.unibios.gr

Unibios Holdings S.A., through its subsidiaries, develops and installs water treatment and recycling systems in Europe, Africa, and the Middle East. It provides installation and rental of faced scaffolding; and maintains and installs heating and air conditioning equipment. The company was formerly known as Biossol SA and changed its name to Unibios Holdings S.A. in July 2008.

Unibios Holdings S.A. Fundamentals Summary

How do Unibios Holdings's earnings and revenue compare to its market cap?
BIOSK fundamental statistics
Market cap€45.76m
Earnings (TTM)€2.39m
Revenue (TTM)€15.31m
19.6x
P/E Ratio
3.1x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOSK income statement (TTM)
Revenue€15.31m
Cost of Revenue€9.19m
Gross Profit€6.12m
Other Expenses€3.72m
Earnings€2.39m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.14
Gross Margin39.96%
Net Profit Margin15.62%
Debt/Equity Ratio35.8%

How did BIOSK perform over the long term?

See historical performance and comparison

Dividends

0.7%
Current Dividend Yield
n/a
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/16 18:04
End of Day Share Price 2026/04/16 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Unibios Holdings S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.